Medtech grants
Explore grants for medtech companies. This directory brings together funding for medical devices, diagnostics, digital health, surgical technology and clinical validation, from health research agencies, national innovation programs, disease foundations and hospital-led challenges.
Showing 265-288 of 2,426 grants
Integrating Biospecimen Science Approaches into Clinical Assay Development
NIH · United States
Funds research into how preanalytical handling of biopsies and other biospecimens distorts biomarker results used in clinical assays.
CHEERS Open Period 1 - All Technical Areas
🇺🇸AFRL · United States
Funds white papers under a standard Broad Agency Announcement inside the Air Force's CHEERS human-performance research strategy.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
NIDCD Early Career Research(ECR) Award
🇺🇸NIH · United States
Funds a self-contained project on hearing, balance, smell, taste, voice, speech or language by a scientist starting an independent career.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
Toward Translation of Nanotechnology Cancer Interventions (TTNCI)
🇺🇸NIH · United States
Funds advanced preclinical work maturing a nanoparticle-based cancer diagnostic or therapeutic toward the National Cancer Institute's own translation pipeline.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development
🇺🇸NIH · United States
Funds building and testing an early medical-device prototype and its matching disease target or assay, for heart, lung, blood or sleep disease.
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
Catalyze: Product Definition Medical Device Prototype Optimization
🇺🇸NIH · United States
Funds refining a medical-device prototype's design, assays and research tools for heart, lung, blood or sleep disease.
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification
🇺🇸NIH · United States
Funds identifying and validating a disease target, then finding a preliminary drug, biologic or combination-product lead against it.
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype
🇺🇸NIH · United States
Funds turning a preliminary drug, biologic or combination-product lead into a combination-product prototype for heart, lung, blood or sleep disease.
A+ Early-Stage Startup Grant Program
🇹🇼ITRI · Taiwan
Funds Taiwan early-stage technology startups moving from functional prototype to MVP validation and market landing.
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the continuation of a dental clinical trial the institute already supports, or a competing revision that changes what it does.
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the planning of a clinical trial in oral, dental or craniofacial health, and then running it, as one phased award.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities
🇺🇸NIH · United States
Funds research into screening, decision-making and care coordination for older adults in populations that get worse healthcare.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.
Exploratory/Developmental Bioengineering Research Grants (EBRG)
NIH · United States
Funds early feasibility work on a new biomedical tool, instrument or method that could improve research, care delivery or accessibility.